-
1Report
المؤلفون: Charite University, Berlin, Germany, MIND Foundation gGmbH, German Federal Ministry of Education and Research, Usona Institute
المصدر: A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression
-
2Report
المؤلفون: Usona Institute
المصدر: Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission
-
3Report
المؤلفون: Usona Institute
المصدر: An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder
Gunderson J: Borderline Personality Disorder, 2nd ed. Washington, DC, American Psychiatric Press, 2000
Nakao K, Gunderson JG, Phillips KA, Tanaka N: Functional impairment in personality disorders. J Pers Disord 1992; 6:24-31
Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006 Jul;63(7):757-66. doi: 10.1001/archpsyc.63.7.757. Erratum In: Arch Gen Psychiatry. 2007 Dec;64(12):1401.
Blum N, St John D, Pfohl B, Stuart S, McCormick B, Allen J, Arndt S, Black DW. Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry. 2008 Apr;165(4):468-78. doi: 10.1176/appi.ajp.2007.07071079. Epub 2008 Feb 15. Erratum In: Am J Psychiatry. 2008 Jun;165(6):777.
McMain SF, Guimond T, Streiner DL, Cardish RJ, Links PS. Dialectical behavior therapy compared with general psychiatric management for borderline personality disorder: clinical outcomes and functioning over a 2-year follow-up. Am J Psychiatry. 2012 Jun;169(6):650-61. doi: 10.1176/appi.ajp.2012.11091416.
Lieb K, Vollm B, Rucker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010 Jan;196(1):4-12. doi: 10.1192/bjp.bp.108.062984.
Nickel MK, Muehlbacher M, Nickel C, Kettler C, Pedrosa Gil F, Bachler E, Buschmann W, Rother N, Fartacek R, Egger C, Anvar J, Rother WK, Loew TH, Kaplan P. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2006 May;163(5):833-8. doi: 10.1176/ajp.2006.163.5.833.
Schulz SC, Zanarini MC, Bateman A, Bohus M, Detke HC, Trzaskoma Q, Tanaka Y, Lin D, Deberdt W, Corya S. Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. Br J Psychiatry. 2008 Dec;193(6):485-92. doi: 10.1192/bjp.bp.107.037903.
Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, Deberdt W, Kryzhanovskaya L, Corya S. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2011 Oct;72(10):1353-62. doi: 10.4088/JCP.08m04138yel.
Pascual JC, Soler J, Puigdemont D, Perez-Egea R, Tiana T, Alvarez E, Perez V. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study. J Clin Psychiatry. 2008 Apr;69(4):603-8. doi: 10.4088/jcp.v69n0412.
Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003 Jun;17(3):233-42. doi: 10.1521/pedi.17.3.233.22147. Erratum In: J Personal Disord. 2003 Aug;17(4):1 p following 369. -
4Report
المؤلفون: Usona Institute, Tiny Blue Dot Foundation, Steadman Philippon Research Institute, Emory University
المساهمون: Charles Raison, Vail Health Behavioral Health Innovation Center Director
المصدر: An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)
-
5Report
المؤلفون: Usona Institute
المساهمون: Benjamin Kelmendi, MD, Assistant Professor
المصدر: Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals with Functional Impairment Related to Mood, Anxiety, Trauma And/or Addiction Symptoms: an Open-label Proof-of-concept Study
-
6Report
المؤلفون: Usona Institute
المصدر: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
-
7Report
المؤلفون: Heffter Research Institute, Usona Institute
المساهمون: Benjamin Lewis, Assistant Professor of Psychiatry
المصدر: PAPR: Psilocybin-assisted Psychotherapy + Mindfulness-Based Stress Reduction (MBSR) for Front-line Healthcare Provider COVID-19 Related Burnout
-
8Report
المؤلفون: Usona Institute, Tiny Blue Dot Foundation
المصدر: Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot Phase
-
9Report
المؤلفون: Oppenheimer Family Psychosocial Oncology and Palliative Care Research Grants, Usona Institute, Carey and Claudia Turnbull Family Foundation, Heffter Research Institute, George Sarlo Foundation, RiverStyx Foundation, Council on Spiritual Practices Fund at the San Francisco Foundation, Nikean Foundation, Jack Smith
المساهمون: Yvan Beaussant, MD, MSci, Sponsor Investigator
المصدر: Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study
-
10Report
المؤلفون: Usona Institute
المصدر: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
-
11Report
المؤلفون: Braxia Scientific Corp., Usona Institute
المصدر: The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study
-
12Report
المساهمون: Joshua Woolley, Assistant Professor
المصدر: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. EClinicalMedicine. 2020 Sep 24;27:100538. doi: 10.1016/j.eclinm.2020.100538. eCollection 2020 Oct. -
13Academic Journal
المؤلفون: Moujaes, Flora, Ji, Jie Lisa, Rahmati, Masih, Burt, Joshua B, Schleifer, Charles, Adkinson, Brendan D, Savic, Aleksandar, Santamauro, Nicole, Tamayo, Zailyn, Diehl, Caroline, Kolobaric, Antonija, Flynn, Morgan, Rieser, Nathalie, Fonteneau, Clara, Camarro, Terry, Xu, Junqian, Cho, Youngsun, Repovs, Grega, Fineberg, Sarah K, Morgan, Peter T, Seifritz, Erich, Vollenweider, Franz X, Krystal, John H, Murray, John D, Preller, Katrin H, Anticevic, Alan
المساهمون: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Science Foundation, Brain and Behavior Research Foundation, Simons Foundation Autism Research Initiative, Heffter Research Institute, Swiss Neuromatrix Foundation, Swiss National Science Foundation under the framework of Neuron Cofund, Usona Institute
المصدر: eLife ; volume 13 ; ISSN 2050-084X
-
14Academic Journal
المؤلفون: Brouwer, Ari, Carhart‐Harris, Robin L., Raison, Charles L.
المساهمون: Usona Institute
المصدر: Pharmacology Research & Perspectives ; volume 12, issue 4 ; ISSN 2052-1707 2052-1707
-
15Academic Journal
المؤلفون: Brouwer, Ari, Raison, Charles L., Shults, F. LeRon
المساهمون: Mary Sue and Mike Shannon Distinguished Chair for Healthy Minds, Children and Families, Usona Institute
المصدر: Religion, Brain & Behavior ; page 1-17 ; ISSN 2153-599X 2153-5981
-
16Academic Journal
المؤلفون: Sherwood, Alexander M., Burkhartzmeyer, Elise K., Williamson, Samuel E., Baumann, Michael H., Glatfelter, Grant C.
المساهمون: National Institute on Drug Abuse, Usona Institute
المصدر: ACS Chemical Neuroscience ; volume 15, issue 2, page 315-327 ; ISSN 1948-7193 1948-7193
-
17Academic Journal
المؤلفون: Davis, Alan K., Timmermann, Christopher, Ortiz Bernal, Ana Maria, Lancelotta, Rafaelle, Nayak, Sandeep, Sepeda, Nathan D., Nikolaidis, Aki, Griffiths, Roland R.
المساهمون: Center for Psychedelic and Consciousness Research, Tim Ferriss, Matt Mullenweg, Craig Nerenberg, Blake Mycoskie, and the Steven and Alexandra Cohen Foundation, Center for Psychedelic Drug Research and Education, Usona Institute
المصدر: Journal of Psychoactive Drugs ; page 1-11 ; ISSN 0279-1072 2159-9777
-
18Academic Journal
المؤلفون: Ort, Andres, Smallridge, John W., Sarasso, Simone, Casarotto, Silvia, von Rotz, Robin, Casanova, Andrea, Seifritz, Erich, Preller, Katrin H., Tononi, Giulio, Vollenweider, Franz X.
المساهمون: Usona Institute
المصدر: iScience ; volume 26, issue 5, page 106589 ; ISSN 2589-0042
-
19Academic Journal
المؤلفون: Sherwood, Alexander M., Burkhartzmeyer, Elise K., Williamson, Samuel E., Faley, Michael T.
المساهمون: Usona Institute
المصدر: ACS Omega ; volume 8, issue 24, page 22132-22137 ; ISSN 2470-1343 2470-1343
-
20Academic Journal
المساهمون: Usona Institute, Heffter Research Institute
المصدر: Journal of Neurochemistry ; volume 162, issue 1, page 60-79 ; ISSN 0022-3042 1471-4159